COMT and schizophrenia: In schizophrenia patients, COMT rs4680GG homozygous patients (with lower dopamine signaling) have a significant GMV reduction in the SN regions compared to A-allele carriers (with higher dopamine signaling) (Ohnishi et al. 2006).